Is Diffuse Large B-cell Lymphoma Still an Unsolved Puzzle in Precision Oncology?

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL), accounting for about 30-40% of all NHL cases. It is an aggressive but potentially curable cancer, with treatment advancements improving survival rates.…







